SkinHealth Systems Statistics
Total Valuation
SKIN has a market cap or net worth of $70.80 million. The enterprise value is $233.76 million.
| Market Cap | 70.80M |
| Enterprise Value | 233.76M |
Important Dates
The next confirmed earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 6.51 million shares outstanding. The number of shares has increased by 2.43% in one year.
| Current Share Class | 6.51M |
| Shares Outstanding | 6.51M |
| Shares Change (YoY) | +2.43% |
| Shares Change (QoQ) | -1.37% |
| Owned by Insiders (%) | 9.06% |
| Owned by Institutions (%) | 28.61% |
| Float | 2.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.74 |
| PS Ratio | 0.24 |
| Forward PS | 0.25 |
| PB Ratio | 1.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.35 |
| P/OCF Ratio | 3.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.64, with an EV/FCF ratio of 11.06.
| EV / Earnings | n/a |
| EV / Sales | 0.81 |
| EV / EBITDA | 11.64 |
| EV / EBIT | n/a |
| EV / FCF | 11.06 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 6.61.
| Current Ratio | 1.76 |
| Quick Ratio | 1.33 |
| Debt / Equity | 6.61 |
| Debt / EBITDA | 14.55 |
| Debt / FCF | 17.36 |
| Interest Coverage | -0.17 |
Financial Efficiency
Return on equity (ROE) is -43.89% and return on invested capital (ROIC) is -1.97%.
| Return on Equity (ROE) | -43.89% |
| Return on Assets (ROA) | -0.54% |
| Return on Invested Capital (ROIC) | -1.97% |
| Return on Capital Employed (ROCE) | -1.35% |
| Weighted Average Cost of Capital (WACC) | 6.19% |
| Revenue Per Employee | $473,158 |
| Profits Per Employee | -$46,385 |
| Employee Count | 613 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, SKIN has paid $4.71 million in taxes.
| Income Tax | 4.71M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.10% in the last 52 weeks. The beta is 1.05, so SKIN's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -59.10% |
| 50-Day Moving Average | 12.70 |
| 200-Day Moving Average | 17.22 |
| Relative Strength Index (RSI) | 40.68 |
| Average Volume (20 Days) | 31,354 |
Short Selling Information
| Short Interest | 7.25M |
| Short Previous Month | 7.18M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 21.74 |
Income Statement
In the last 12 months, SKIN had revenue of $290.05 million and -$28.43 million in losses. Loss per share was -$4.44.
| Revenue | 290.05M |
| Gross Profit | 192.45M |
| Operating Income | -4.31M |
| Pretax Income | -23.73M |
| Net Income | -28.43M |
| EBITDA | 20.08M |
| EBIT | -4.31M |
| Loss Per Share | -$4.44 |
Balance Sheet
The company has $204.07 million in cash and $367.04 million in debt, with a net cash position of -$162.97 million or -$25.04 per share.
| Cash & Cash Equivalents | 204.07M |
| Total Debt | 367.04M |
| Net Cash | -162.97M |
| Net Cash Per Share | -$25.04 |
| Equity (Book Value) | 55.57M |
| Book Value Per Share | 8.54 |
| Working Capital | 127.04M |
Cash Flow
In the last 12 months, operating cash flow was $21.96 million and capital expenditures -$817,000, giving a free cash flow of $21.14 million.
| Operating Cash Flow | 21.96M |
| Capital Expenditures | -817,000 |
| Depreciation & Amortization | 24.39M |
| Net Borrowing | -20.86M |
| Free Cash Flow | 21.14M |
| FCF Per Share | $3.25 |
Margins
Gross margin is 66.35%, with operating and profit margins of -1.49% and -9.80%.
| Gross Margin | 66.35% |
| Operating Margin | -1.49% |
| Pretax Margin | -8.18% |
| Profit Margin | -9.80% |
| EBITDA Margin | 6.92% |
| EBIT Margin | -1.49% |
| FCF Margin | 7.29% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.43% |
| Shareholder Yield | -2.43% |
| Earnings Yield | -40.85% |
| FCF Yield | 29.86% |
Analyst Forecast
The average price target for SKIN is $15.67, which is 44.03% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.67 |
| Price Target Difference | 44.03% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 0.66% |
| EPS Growth Forecast (3Y) | -13.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 14, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 14, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
SKIN has an Altman Z-Score of -0.39 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.39 |
| Piotroski F-Score | 5 |